Compound overview
BPC-157: Research Overview, Mechanisms & Peer-Reviewed Studies (2026)
· SupplyPeptides Research Hub
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide frequently discussed in preclinical research literature. UK laboratories sourcing BPC-157 as a research material typically need three things: a clear understanding of what the compound is, pointers into the primary literature, and verifiable batch quality documentation — not marketing claims about human outcomes.
This overview is written for researchers and procurement teams. It does not provide protocols for human use.
What BPC-157 is (research context)
BPC-157 is a 15-amino-acid sequence derived from a larger gastric protein sequence studied in experimental models. In supplier catalogues it is usually offered as a lyophilised research peptide with stated purity (commonly HPLC ≥98–99%) and a Certificate of Analysis (COA) for the batch.
When evaluating any vial labelled BPC-157, confirm identity and purity against the COA lot number on the product page or in the COA library. Sequence-level identity and HPLC purity are separate signals — both matter for reproducible laboratory work.
Mechanisms discussed in the literature
Peer-reviewed work on BPC-157 spans multiple experimental systems. Themes that recur in the literature include angiogenesis-related signalling, nitric-oxide pathway interactions, and tissue-response models in animals. Those themes are research observations under controlled conditions — they are not clinical indications and should not be read as product claims.
For primary sources, start with structured PubMed searches rather than secondary blogs. Useful query seeds include:
When citing studies in your own write-ups, prefer full texts, note the model organism and dose units used in that paper, and avoid extrapolating animal data to human use.
How UK labs typically evaluate supply
- Exact identity — product title, sequence (if published), and CAS or equivalent identifiers where available.
- Batch COA — HPLC purity and, ideally, mass-spec identity for the lot you receive.
- UK fulfilment — stock location and tracked dispatch affect timeline more than catalogue breadth alone.
- RUO framing — suppliers that push human-use language create regulatory and scientific risk for institutional buyers.
Storage and handling (laboratory)
Lyophilised peptides are typically stored frozen or refrigerated per institutional SOP and supplier storage notes. After reconstitution, aliquoting and freeze–thaw discipline matter for assay consistency. Use the laboratory reconstitution calculator only to derive concentration from mass and diluent volume — never as a human dosing tool.
Related reading
Frequently asked questions
Is BPC-157 for human use?
No. SupplyPeptides supplies BPC-157 strictly for laboratory and in-vitro research use only. It is not intended for human or veterinary consumption, dosing, or therapeutic use.
Do you publish a COA for BPC-157 batches?
Where batch metafields are populated, Certificates of Analysis are linked from the product page and searchable in our COA library by lot number. Otherwise you can request the PDF from support.
Where can I buy BPC-157 for research in the UK?
SupplyPeptides dispatches research peptides from UK stock via tracked Royal Mail. Browse the catalogue and always confirm RUO positioning and batch documentation before purchase.